![]() Prolaris Prolaris is a genomic test for predicting prostate cancer aggressiveness developed by Myriad Genetics. | ||
Founding Date | Founding Date 2018 | Founding Date 2010 |
Type | Type Private | Type Subsidiary |
Tags | ||
Locations | Locations New York, US HQ Aventura, US Beverly Hills, US Great Neck, US Irvine, US Las Vegas, US Miami, US see more | Locations Salt Lake City, US HQ |
Employees | Employees 913% increase | Employees N/A |

Prolaris is a genomic test for predicting prostate cancer aggressiveness developed by Myriad Genetics.
View company